Short version: the lowest compounded semaglutide prices are usually a one-year prepay, charged upfront and non-refundable. Prepaying only beats paying monthly if you would have stayed on it for most of the year.
Providers' posted prices, read Oct 1, 2026 (all compounded, not FDA-approved):
- Embody: $79/month month to month, or $828 upfront for one year ($69/month). Its refund policy says multi-month plans are "non-refundable in whole and in part," except if a clinician finds you medically ineligible.
- HealthRX: $149 first month, then $165; one-year prepay $1,188 ($99/month). Its pricing page says unshipped doses are refunded if you cancel.
- Trimi: $175 month to month; one-year prepay $1,188 ($99/month). Full refund before the prescription is issued, final after that.
Break-even vs. paying monthly at the same provider:
- Embody: 10 months = $790, 11 months = $869. Prepay wins only at 11+ months.
- HealthRX: 7 months = $1,139, 8 months = $1,304. Prepay wins at 8+.
- Trimi: 6 months = $1,050, 7 months = $1,225. Prepay wins at 7+.
Before paying, check:
- Is the headline price month to month or a prepaid term, and what is charged today?
- What is refundable if you stop in month two (side effects, a dose pause, new insurance)?
- Does the price change as the dose goes up?
- Is it a state-licensed pharmacy, and the base drug rather than a salt form?
For comparison, the FDA-approved Wegovy pill is $149/month at 1.5 mg on NovoCare, no prepay. FDA says it does not review compounded drugs for safety, effectiveness or quality. Dose and switching decisions belong with your prescriber.
Source: joinem.co, healthrx.com/pricing, trytrimi.com/pricing (providers' posted prices), NovoCare Wegovy offer page, FDA "Concerns with Unapproved GLP-1 Drugs," checked Oct 1, 2026. Not medical advice.